OUTCOME Receives Pivotal Patent Approval for Web-Based Outcomes Assessment and Quality...
* Reuters is not responsible for the content in this press release.
OUTCOME Receives Pivotal Patent Approval for Web-Based Outcomes Assessment and Quality Measurement Technology CAMBRIDGE, Mass.--(Business Wire)-- Outcome Sciences, Inc. (OUTCOME), the leading provider of patient registries, studies, and technologies for evaluating real-world outcomes and measuring healthcare quality, announced today that the U.S. Patent and Trademark Office on April 1, 2008 approved the issuance of a pivotal patent that covers several innovative aspects of the company's industry-leading OUTCOME System(R). The patent, entitled "Apparatus and methods for determining and processing medical outcomes," covers a critical set of innovations related to the collection, analysis, and reporting of clinical outcomes, including physician and hospital performance. The OUTCOME System was created specifically for collecting and evaluating real-world outcomes and helping physicians and hospitals measure and improve performance. It is a widely used system that has captured data for hundreds of programs, involving millions of patients, across 42 countries. It has been used in a leading number of patient registries and real-world studies as well as in award-winning quality measurement programs for medical associations, hospitals, and physician offices. The OUTCOME System is a highly scalable, web-based technology enabling state-of-the-art real-time data capture, benchmarking, and reporting, as well as providing hospitals and physicians with real-time access to point-of-care tools that have been demonstrated to improve performance. The OUTCOME System allows for integration with external databases and systems and is interoperable with a growing number of practice management and electronic health records. "OUTCOME has achieved its substantial market-leading position through superior customer value, scientific leadership, and breakthrough technology," said Richard Gliklich, MD, CEO of OUTCOME. "The issuance of this new patent validates our scientific and technological leadership in the areas of outcomes assessment and quality measurement. We believe that the patented methods, such as those related to reporting and benchmarking, are and will be fundamental to how these programs are conducted now and in the future. This patent is part of a growing portfolio in this field that we have been developing for more than 10 years." More detailed information regarding the full context and abstract of the patent can be accessed at the U.S. Patent and Trademark Office website at http://patft.uspto.gov. Search for patent number 7,353,238. About OUTCOME OUTCOME is the leading provider of patient registries, studies, quality improvement programs, and integrated technologies for evaluating real-world outcomes. OUTCOME provides services and technologies focused on evaluating the safety, effectiveness, and quality of healthcare products and services. The company has designed, developed, and managed more than 100 patient registries, including many of the largest and most well-recognized programs for disease outcomes and patient safety. The Outcome TotalQuality(TM) system is the leading clinical quality measurement solution supporting a large number of national and international quality improvement and reporting programs. OUTCOME is also an AHRQ DEcIDE Research Center, a component of the "Effective Health Care" initiative sponsored by the U.S. Dept. of Health and Human Services. OUTCOME was selected by the Agency for Healthcare Research and Quality to lead the effort to create the patient registries handbook "Registries for Evaluating Patient Outcomes: A User's Guide," released in May 2007. For more information, please visit www.outcome.com. OUTCOME Renee Holmes, 617-715-6882 rholmes@outcome.com or FD Business Communications Theresa Kelleher, 212-850-5663 theresa.kelleher@fd.com Copyright Business Wire 2008
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.



Follow Reuters